Header Logo

Mohit Chopra

Concepts (130)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
4
2025
82
0.710
 Why?
Depressive Disorder
3
2009
284
0.700
 Why?
Stress Disorders, Post-Traumatic
3
2016
397
0.700
 Why?
Opioid-Related Disorders
5
2025
507
0.580
 Why?
Memantine
3
2014
23
0.570
 Why?
Methadone
3
2025
134
0.570
 Why?
Health Status
2
2016
436
0.470
 Why?
Excitatory Amino Acid Antagonists
2
2013
37
0.470
 Why?
Social Stigma
1
2016
73
0.470
 Why?
Obsessive-Compulsive Disorder
1
2011
36
0.360
 Why?
Patient Acceptance of Health Care
1
2016
480
0.350
 Why?
Benzodiazepines
1
2011
100
0.350
 Why?
Narcotics
2
2025
58
0.350
 Why?
Disulfiram
2
2025
5
0.320
 Why?
Alzheimer Disease
3
2014
721
0.310
 Why?
Quality of Life
2
2016
1230
0.310
 Why?
Depressive Disorder, Major
3
2011
255
0.310
 Why?
Apolipoprotein E4
1
2009
46
0.300
 Why?
Antipsychotic Agents
1
2011
301
0.300
 Why?
Methadyl Acetate
1
2008
1
0.300
 Why?
Reward
1
2009
87
0.300
 Why?
Psychiatric Status Rating Scales
2
2013
390
0.290
 Why?
Narcotic Antagonists
2
2014
136
0.290
 Why?
Naloxone
1
2008
60
0.280
 Why?
Buprenorphine
2
2014
192
0.270
 Why?
Cognition Disorders
1
2008
217
0.260
 Why?
Aging
1
2013
745
0.260
 Why?
Alcohol Deterrents
1
2025
6
0.230
 Why?
Dementia
1
2008
260
0.230
 Why?
Geriatric Assessment
1
2006
163
0.230
 Why?
Long-Term Care
1
2006
177
0.220
 Why?
Aged
12
2016
14472
0.220
 Why?
Male
19
2025
29927
0.210
 Why?
Opiate Substitution Treatment
3
2025
206
0.210
 Why?
Female
18
2025
32912
0.200
 Why?
Hallucinations
1
2003
16
0.200
 Why?
Vitamin E
2
2014
54
0.200
 Why?
Depression
3
2016
894
0.200
 Why?
Treatment Refusal
1
2003
56
0.200
 Why?
Mental Competency
1
2003
61
0.190
 Why?
Anxiety
3
2016
425
0.190
 Why?
Comorbidity
3
2016
1120
0.190
 Why?
Informed Consent
1
2003
140
0.190
 Why?
Antioxidants
2
2014
252
0.180
 Why?
Attitude to Health
1
2003
289
0.170
 Why?
Humans
21
2025
63511
0.160
 Why?
Nursing Homes
1
2006
670
0.160
 Why?
Decision Making
1
2003
407
0.150
 Why?
Double-Blind Method
6
2025
741
0.140
 Why?
Severity of Illness Index
5
2014
1553
0.130
 Why?
Veterans
3
2016
765
0.130
 Why?
Dose-Response Relationship, Drug
3
2025
864
0.130
 Why?
Cyclohexanecarboxylic Acids
1
2014
9
0.110
 Why?
Dopamine Agents
1
2014
11
0.110
 Why?
Amines
1
2014
30
0.110
 Why?
Sertraline
1
2014
58
0.110
 Why?
gamma-Aminobutyric Acid
1
2014
75
0.100
 Why?
Aged, 80 and over
4
2014
5474
0.100
 Why?
Alcohol-Related Disorders
1
2013
37
0.100
 Why?
Alcoholism
1
2016
318
0.100
 Why?
Adult
8
2025
16837
0.100
 Why?
Longitudinal Studies
2
2013
1256
0.090
 Why?
Motivation
1
2014
286
0.090
 Why?
Disease Progression
2
2014
1173
0.090
 Why?
Combat Disorders
1
2011
11
0.090
 Why?
Patient Compliance
2
2014
360
0.090
 Why?
Activities of Daily Living
2
2014
291
0.090
 Why?
Life Change Events
1
2011
66
0.090
 Why?
Internet
1
2014
469
0.090
 Why?
Wounds and Injuries
1
2013
246
0.080
 Why?
Amphetamine-Related Disorders
1
2009
12
0.080
 Why?
Chronic Disease
1
2013
753
0.080
 Why?
Methamphetamine
1
2009
26
0.080
 Why?
Directive Counseling
1
2009
39
0.080
 Why?
Arkansas
1
2008
4
0.080
 Why?
Benzhydryl Compounds
1
2009
51
0.080
 Why?
Logistic Models
2
2011
1276
0.070
 Why?
Cocaine
2
2025
101
0.070
 Why?
Secondary Prevention
1
2009
164
0.070
 Why?
United States
3
2013
7852
0.070
 Why?
Self Concept
1
2008
111
0.070
 Why?
Paroxetine
2
2004
16
0.070
 Why?
Middle Aged
6
2025
17644
0.070
 Why?
Substance Withdrawal Syndrome
1
2008
123
0.070
 Why?
Sex Characteristics
1
2008
203
0.070
 Why?
Neuropsychological Tests
1
2008
392
0.060
 Why?
Psychometrics
1
2008
376
0.060
 Why?
Multivariate Analysis
1
2008
937
0.060
 Why?
Mental Health Services
2
2011
288
0.060
 Why?
Dysthymic Disorder
1
2005
8
0.060
 Why?
Psychotherapy
1
2006
97
0.060
 Why?
Mortality
1
2006
160
0.060
 Why?
Pindolol
1
2004
2
0.060
 Why?
Prolactin
1
2004
40
0.050
 Why?
Antidepressive Agents
1
2006
225
0.050
 Why?
Antidepressive Agents, Second-Generation
1
2004
30
0.050
 Why?
Tryptophan
1
2004
57
0.050
 Why?
Disability Evaluation
1
2005
217
0.050
 Why?
Treatment Outcome
3
2025
5699
0.050
 Why?
Combined Modality Therapy
2
2014
374
0.050
 Why?
Adrenergic beta-Antagonists
1
2004
150
0.050
 Why?
Cross-Sectional Studies
2
2011
2578
0.050
 Why?
Hydrocortisone
1
2004
193
0.050
 Why?
Drug Therapy, Combination
2
2014
466
0.050
 Why?
Surveys and Questionnaires
1
2008
2681
0.040
 Why?
Follow-Up Studies
1
2005
2462
0.040
 Why?
Primary Health Care
1
2005
690
0.040
 Why?
Adolescent
1
2009
6248
0.040
 Why?
Remission Induction
2
2011
148
0.030
 Why?
Diagnostic and Statistical Manual of Mental Disorders
2
2011
119
0.030
 Why?
Retrospective Studies
1
2008
6673
0.030
 Why?
GABA Agonists
1
2014
4
0.030
 Why?
Diagnosis, Dual (Psychiatry)
1
2014
86
0.030
 Why?
Cross-Over Studies
2
2004
163
0.030
 Why?
Cholinesterase Inhibitors
1
2014
47
0.030
 Why?
Residence Characteristics
1
2014
219
0.020
 Why?
Medication Adherence
1
2014
204
0.020
 Why?
Recurrence
1
2014
644
0.020
 Why?
Risk Factors
2
2011
5359
0.020
 Why?
Caregivers
1
2014
272
0.020
 Why?
Analgesics, Opioid
1
2014
536
0.020
 Why?
Self Report
1
2010
375
0.020
 Why?
Sex Factors
1
2011
978
0.020
 Why?
Alcohol Drinking
1
2010
315
0.020
 Why?
Pilot Projects
1
2009
1008
0.020
 Why?
Mass Screening
1
2011
694
0.010
 Why?
Fluoxetine
1
2004
44
0.010
 Why?
Young Adult
1
2014
4700
0.010
 Why?
Drug Administration Schedule
1
2004
299
0.010
 Why?
Substance-Related Disorders
1
2011
734
0.010
 Why?
Chopra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (130)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_